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Parathyroid hormone raises cytosolic calcium in pancreatic islets:
Study on mechanisms. The pancreatic islets of Langerhans are targets
for PTH and the action of the hormone on the islet is most likely
mediated through the ability of VFH to increase cytosolic calcium
([Ca2]) of the islet cells. Although direct evidence for such an effect
has been clearly demonstrated, the mechanisms through which the
hormone exerts such an action are not elucidated. The present study
examined these questions using pancreatic islets isolated from normal
rats. Both 1-34 and 1-84 PTH produced a dose dependent increase in
[Ca2i1 of the islets but the effect of the latter was significantly (P <
0.01) greater than that of the former. This action of PTH was signifi-
cantly (P < 0.01) decreased by the use of PTH antagonist or by
verapamil. The G protein activator (GTPyS) mimicked the effect of
PTH while pertussis toxin and the U protein inhibitor (GDPI3S) signif-
icantly reduced the PTH-induced rise in [Ca2i. Dibutyryl cAMP, and
phorbol ester 12-myristate 13 acetate increased [Ca2i of pancreatic
islets in a dose dependent manner and the effect was inhibited (P <
0.01) by verapamil. Staurosporine inhibited the effect of TPA as well as
of 1-84 PTH on [Ca2]1 of the islets. These data indicate that: (I) PTH
increases [Ca2] of pancreatic islets, (2) this action is partly receptor
mediated and is produced by activation of L-type calcium channels
through stimulation of G protein(s), and (3) the rise in [Ca2]1 is due to
both stimulation of cAMP generation and activation of protein kinase C.
Pancreatic islets are targets for parathyroid hormone (PTH)
in that the acute exposure to the hormone stimulates cyclic
AMP generation [1], protein kinase activity [2] and insulin
secretion [1] by these structures. Further, the chronic exposure
to PTH is associated with inhibition of insulin secretion by the
islets [3]. The effects of PTH on insulin secretion in both the
acute [1] or the chronic setting [3] are mediated, at least in part,
through the effect of the hormone on cytosolic calcium
([Ca2]1). Indeed, the acute exposure of the islets to PTH
causes a rise in [Ca2] and stimulation of insulin secretion [1],
while the chronic exposure to excess PTH is followed by
sustained elevation in [Ca2]1 and inhibition of insulin secretion
[3].
The mechanisms through which PTH augments entry of
calcium into islets are not defined. The present study was
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undertaken to examine the various pathways involved in the
PTH-induced rise in [Ca2]1 of pancreatic islets.
Methods
One hundred and seventy male Sprague-Dawley rats weigh-
ing 170 to 250 g were studied. They were fed normal rat chow
diet (ICN Nutritional Biochemical, Cleveland, Ohio, USA) and
allowed to drink water ad libitum. Upon sacrificing the animal,
the pancreas was dissected free of adipose tissue. The islets
were isolated by the coliagenase digestion method of Lacy and
Kostianovsky [4], and picked free of exocrine tissue under a
dissecting microscope. Islets were isolated from the pancreas of
each rat and were utilized in one study for the measurement of
basal [Ca2] and the effect of various experimental procedures
on [Ca2]1 after 10 minutes of the exposure of the islets to
various agents.
[Ca2]1 of the pancreatic islets was measured with fura 2/AM
(Sigma Chemical Co., St. Louis, Missouri, USA) as described
by Komatsu et a! [5] and reported by our laboratory [6, 7]. This
technique utilizes entire islets and not dispersed islet cells. One
hundred and fifty islets, isolated from the pancreas of one rat
were loaded with fura 2/AM by incubation in 2 JiMoffura 2/AM
for 30 minutes in an incubation medium containing the following
in mM: 128 NaC1, 3.5 KCI, 1.0 MgCI2, 1.2 KH2PO4, 1.0 CaC12,
1.25 NaHCO3, 20 HEPES, 2.8 glucose and 5 mg/mi BSA (pH
7.4). To remove the unicorporated probe, the islets were
centrifuged for 3 to 5 seconds in an Eppendorf microfuge and
washed twice and finally suspended in 2 ml of the incubation
media. Measurement of fluorescence was done with Perkin
Elmer LS SB, (Perkin-Elmer Corp., Norwalk, Connecticut,
USA) at an excitation wavelength of 340 nm and emission
wavelength of 510 nm. Maximal fluorescence (Fmax) and mini-
mal fluorescence (Fmjn) were estimated as previously reported.
The islets were lysed by 0.07% Triton X-100 to obtain Fmax,
subsequently 5 mti EGTA was added to obtain Fmjn (final pH
8.5). Islets were washed before each experiment and the
above-mentioned calibration for fura 2 signal was performed
after each experiment. To eliminate the effect of autofluores-
cence due to cuvette, medium and unloaded islets, autofluores-
cence was measured before each experiment and was ac-
counted for by setting the fluorometer to autozero before each
measurement. Calculation of [Ca2] was made utilizing the
Grynkiewicz equation [Ca2]1 = Kd(F — Fmjn)/(Fmax — F) [8],
where Kd is the dissocation constant for Ca2-fura 2 and was
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assumed to be 225 nM. Both basal [Ca2i and the effect of
different agents on [Ca2]1 were evaluated. The following
studies were performed:
(1.) Measurements of basal [Ca2j1 of the islets incubated in
media containing 1.0 m calcium (150 rats) and of islets
incubated in media containing no calcium and 0.2 mM
EGTA (20 rats).
(2.) Dose response relationship between 1-84 PTH (Sigma
Chemical Co., lot #129F9560) or 1-34 PTH (Bachem,
Torrance, California, USA) and [Ca2]1 in the presence or
absence of calcium in the media.
(3.) Effect of P1'H antagonist ([Tyr-34] bPTH (7-34) NH2)
(Bachem) on the changes in [Ca2]1 induced by both
moieties of the hormone.
(4.) Dose response between dibutyryl cAMP (Sigma) and
[Ca2i1 in the presence and absence of calcium in media.
(5.) Dose response between the phorbol ester 12-myristate-13
acetate (TPA) (Sigma) and [Ca2]1 in the presence and
absence of calcium in the media.
(6.) Effect of verapamil (Sigma) on the changes in [Ca2]
induced by PTH, dibultyryl cAMP and TPA.
(7.) Effect of staurosporine (Calbiochem, San Diego, Califor-
nia, USA, lot #90X002) on the changes in [Ca24j induced
by PTH and TPA.
(8.) Combined effect of verapamil and staurosporine on the
changes in [Ca211 induced by PTH.
(9.) Effect pertussis toxin (Sigma) or G protein inhibitor
(GDPI3S) on 1-84 PTH-induced rise in [Ca2]1.
(10.) Effect of U protein activator (GTPyS) on [Ca24i.
Dibutyryl cAMP, verapamil, TPA and staurosporine were
dissolved in DMSO (Sigma). The latter by itself did not affect
[Ca2] of islets. Pertussis toxin, GTP7S and GDPS were
dissolved in distilled water.
The potency of equimolar amounts of 1-34 and 1-84 PTH used
in our studies was tested by measuring the effects of these
Fig. 1. Frequency distribution of basal levels
of [Ca2 of pancreatic islets of normal rats.
moieties on cAMP generation by renal tubular cells. The cells
were separated by digestion with collagenase for 30 minutes
followed by purification with percoll gradient. The effects of 20
minutes incubation at 37°C with various doses of PTH (0.5 x
iO, i0 and 2 x i0 M) in the presence of 10 mM
theophylline on the generation of cAMP were examined, cAMP
was measured by using cAMP [12511 assay kit (Amersham, Co.,
Arlington Heights, Illinois, USA). The details of the assay have
been previously described by us [91.
Statistical analysis was made with paired and unpaired Stu-
dent's t-test and the data are presented as mean SE. P values
below 0.05 were considered significant. For the evaluation of
normal distribution of data, the goodness of fit test was utilized.
Results
The basal levels of [Ca2]1 in intact pancreatic islets obtained
from 150 rats ranged between 64 and 103 rIM with a mean value
of 84 0.7 n. This value is not different from that (72 10.1
nM) reported by Komatsu et al [5] and from that (82 5.5 nM)
observed previously by us [6]. The levels of [Ca2]1 in the islets
of the normal rats followed normal distribution (= 0.48, Fig.
1). The suspension of the islets in calcium free medium resulted
in a decrease in their [Ca211; the values of [Ca2] in these islets
obtained in 20 rats ranged 44 to 77 nM with a mean of 63 2.4
n, a value significantly (P < 0.01) lower than that of islets
suspended in media containing 1 m calcium.
Both 1-84 PTH and 1-34 PTH produced a dose dependent
significant (P < 0.01) increments in [Ca2]1, but the effect of
1-84 PTH was significantly (P < 0.01) higher than equimolar
amounts of 1-34 PTH (Figs. 2 and 3). The increments in [Ca2]1
with 0.5, 1 and 2 x i0 M of 1-84 PTH were 62 5.6, 115
12.8 and 137 8.9 n above basal level. In contrast, both 0.25
and 0.5 x iO M 1-34 PTH increased [Ca2]1 by 33 1.3 and
34 4.3 nM; I and 2 X i0 M 1-34 PTH caused a rise of 55
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Fig. 2. Dose-response relationship between the rise in cytosolic cal-
cium (1 Ca2J1) and 1-84 PTH. Each data point is the mean of 6 to 7
studies and brackets denote 1 SE.
1-34 PTH, x 1O-7M
Fig. 3. Dose-response relationship between the rise in cytosolic cal-
cium ([Ca2j) and 1-34 PTH. Each data point represents the mean of 5
to 7 studies and brackets denote I SE.
Table 1. Effects of 1-34 and 1-84 PTH on cAMP produced by renal
tubular cells incubated for 20 minutes with the hormone in the
presence of 10 mas theophylline
Dose of PTH
cAMP pmol/mg proteinl20 mm
0.5 X 10 M l0 M 2 x lO M
1-34 PTH 71 4.6 89 8.2 110 10.0
1-84 PTH 63 7.6 75 9.1 99 26.0
Data are presented as mean of three studies SE. cAMP generated in
the presence of vehicle only was 35 3.5 pmol/mg protein/20 mm.
**UIrm
30±7.5 70±6.7
% Inhibition
*
46±2.8 72±2.1
% Inhibition
Fig. 4. The rise in cytosolic calcium ([Ca2 f]) induced by io— M 1-34
(A) or 1-84 PTH (B) and the effect of PTH antagonist ([Tyr-34] bPTH
(7-34) NH2) on the PTH-induced rise [Ca2 7. Each column represents
the mean value of 4 to 6 studies and brackets denote 1 SE, * P< 0.01 vs.
PTH alone, and ** P < 0.01 vs. PTH alone and PTH + antagonist (200
X l0 M). Symbols are: (0) PTH alone; () PTH + antagonist (200 x
10); (1110) PTH + antagonist (500 x 10—v).
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1.9 and 55 5.1 flM in [Ca2]1 of islets. These differences in the
effects of the two moieties of the hormone are not due to
differences in their potency as assessed by their effects on
cAMP production by the renal tubules (Table 1). There were no
significant differences in cAMP generation by the renal cells
after their exposure to 1-34 or 1-84 PTH.
The PTH antagonist ([Tyr-34} bPTH (7-34) NH2) in a molar
concentration of 200 and 500 times that of PTH did not induce
a rise in [Ca2] by itself but partially blocked the 1-34 and 1-84
PTH-induced rise in [Ca2]1, P <0.01 (Fig. 4). The effect of 1-84
PTH on [Ca2]1 was also partially blocked by 20 and 60 tM
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Fig. 5. Effect of various doses of verapamil and staurosporine (10_8 M)
andof verapamil (20 i) and staurosporine (10_s M) on the 1-84 PTH
induced rise in [Ca2],. Each column represent the mean values of 6 to
7 studies and brackets denote I SE. Symbols are: (U) PTH alone; ()
PTH + verapamil20 jsM; (U) PTH + verapamil 60 /SM; (1111) staurospo-
rifle; (ElI) PTH + staurosporine + verapamil. *p < 0.01 vs. PTH alone.
< 0.01 vs. all groups.
100 -
d-cAMP, jim
Fig. 6. Dose-response relationship between the rise in cytosolic cal-
cium ([Ca27,) and dibutytyl cyclic AMP (d-cAMP). Each data point
represent the mean of 6 to 7 studies and brackets denote 1 SE.
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Fig. 8. Dose-response relationship between the rise in cytosolic cal-
cium ([CaA7,) and phorbol ester 12-myristate-13 acetate (TPA). Each
data point represents the mean value of 4 studies and brackets denote
1 SE.
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Fig. 7. Effect of verapamil on the rise in [Ca'7, induced by 200 p.M of
dibutyryl cyclic AMP (d-cAMP). Each column represent the mean of 5
studies and brackets denote 1 SE. * P< 0.01. Symbols are: (U) d-cAMP
alone; () d-cAMP + verapamil 20 p.M; P < 0.01.
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verapamil with the percent inhibition by these two doses being
similar (55 3.3% and 55 3.2%, respectively; Fig. 5).
Dibutyryl cAMP also produced a significant (P < 0.01) rise in
[Ca2]1 of islets with the change being 76 3.2 flM and 96 3.2
n with 50 and 200 M of the agent. Increasing the concentra-
tion of dibutyryl cAMP to 400 jM did not produce further
increment in [Ca211 and the value of rise in [Ca211 with this
dose being 94 6.9, (Fig. 6). Verapamil in a concentration of 20
sM caused a significant (P < 0.01) blockage (83 6.1%) of the
dibutyryl cAMP-induced rise in [Ca2] (Fig. 7).
TPA produced a dose dependent significant increments in
[Ca2]1 of pancreatic islets (Fig. 8). This effect of TPA was
modestly blocked by 20 p.M verapamil (17 4.1%, P < 0.05),
but markedly inhibited (78 2.3%) by 10—8 M staurosporine
(Fig. 9). The same concentration of staurosporine also signifi-
cantly (P < 0.01) blocked (57 2.9%) the 1-84 PTH-induced
rise in ICa21i of pancreatic islets (Fig. 5). The combination of
20 p.M verapamil and 10—8 M staurosporine produced signifi-
cantly (P < 0.01) greater inhibition (75 3.3%) of the 1-84 PTH
rise in islet [Ca2]1 than either agent alone (Fig. 5). PTH,
dibutyryl cyclic AMP or TPA failed to increase [Ca2i of islets
when the latter were incubated in a calcium free media.
Incubation of islets with 10 ng/ml pertussis toxin for two
hours at 37°C or their pretreatment for two minutes with 200 /.LM
of G protein inhibitor (GDPI3S) caused a marked and significant
reduction in the 1-84 PTH-induced rise in [Ca2]1. The mean
increments in islet [Ca211 induced by 1 x iO M 1-84 PTH in
the presence of these agents were 12 6.2 nM (from 91 3.2 to
103 3.9nM)and 11 1.1 nM(from90 3.8to 101 4.8nM)
compared to 115 12.8 nM (from 92 2.2 to 207 13.3 flM)
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Fig. 9. Effect of verapami! or staurosporine on the TPA-induced rise in
cytosolic calcium ([Ca2'7,). Symbols are: (0) TPA alone; () TPA +
verapamil 20 tsi; (DIII)) TPA + staurosporine 108M; P < 0.01.
induced by a similar dose of PTH alone. A dose of 100 j.tM G
protein activator (GTPyS) produced a significant (P < 0.01) rise
in islet [Ca2], of 49 7.9 flM (from 90 4.5 to 139 6.9 flM).
Discussion
The results of the present study show that the basal levels of
[Ca2]1 in pancreatic islets of normal rats vary over a wide range
but these values follow a normal distribution. This phenomenon
is similar to that observed in other cells such as polymorpho-
nuclear leukocytes [10], synaptosomes [11] and thymocytes
[12]. Further, as in other cells [12, 13], incubation of pancreatic
islets in a calcium-free medium resulted in a fall in their basal
levels of cytosolic calcium.
We have previously reported that 1-34 PTH causes a gradual
increase in [Ca2], of pancreatic islets. The data of the present
study further shows that 1-84 PTH also increases [Ca2] of
pancreatic islets in a dose dependent manner and that this effect
of 1-84 occurs earlier and is greater than that produced by
equimolar amounts of 1-34 PTH. This different effect of 1-34
and 1-84 on islet [Ca2] is similar to observations in other
systems showing a greater effect of 1-84 PTH on beating of
heart cells [14], rise in [Ca2]1 of isolated cardiac myocytes [15],
myocardial bioenergetic [16], fatty acid oxidation by skeletal
muscles [17], phytohemaglutinin-induced T cell proliferation
[18], and on inhibition of mitogen-induced B cell proliferation
[19]. These observations suggest that the biological activity of
PTH in regard to these systems including the islets may reside
in a bigger fragment of the hormone that contains the 1-34
moiety, or in both the 1-34 fragment and another fragment of
carboxyterminal moiety, or that the intact hormone attaches
more tightly to its receptor.
The high dose of PTH required for its in vitro effect on the
[Ca2], of islets may raise doubt about the physiological rele-
vance and/or significance of such as action. It is of interest,
however, that most of the in vitro actions of PTH on cells that
are not traditional targets for the hormone such as the heart
cells (14], polymorphonuclear leukocytes [20, 21], T cells [18],
and B cells [19] and muscular smooth muscle cells [22] also
require a high dose of the hormone. Several reasons may
explain such a phenomenon without necessarily excluding a
physiological significance of such non-traditional actions of
PTH. These include: (a) the action of PTH may not be mediated
by a hormone-receptor interaction, and hence requires large
amounts of PTH; this is unlikely since PTH augments cAMP
production by pancreatic islets [1] and its action on [Ca2]1 was
blocked significantly by PTH antagonists; (b) this effect of PTH
is mediated by interaction with PTH receptors that may be
present at low concentrations or may have low affinity and,
therefore, requires higher amount of PTH; and/or (c) the PTH is
being degraded by cell surface proteases and/or by proteolytic
enzymes generated during the isolation and preparation of the
islets.
The PTH antagonist ([Tyr-34] bPTH (7-34) NH2) interferes
with the action of 1-34 PTH by blocking its attachment to the
PTH receptor [23]. Our finding that this antagonist in a molar
concentration of 500 times that of PTH produced 70% inhibition
of the action of both 1-34 and 1-84 PTH indicates that the major
part of the effect of PTH on the rise in [Ca2], of pancreatic
islets is receptor mediated, and that about 30% of the effect of
PTH may not be receptor mediated. It further demonstrates
that the effect of 1-84 on [Ca2] of islet requires the presence of
the 1-34 fragment of the hormone. Further support for PTH-
receptor interaction in the pancreatic islets is provided by
previous observations that PTH stimulates cAMP generation by
the islets [1].
Verapamil interferes with the entry of calcium into cells by
blocking L-type voltage dependent calcium channels [24]. The
pancreatic islets possess such channels [25]. Therefore, our
finding that verapamil inhibited 55% of the PTH-induced rise in
[Ca2]1 indicates that the hormone activates these channels but
such an effect is only partly responsible for the rise in [Ca2]1.
If these data and those of the effects of PTH antagonist allow
quantitative interpretation of the results, one may suggest that
the effects of PTH on the L-type calcium channels is partly if
not totally receptor mediated.
It has been shown that the agonists that stimulate cAMP
generation activate L-type calcium channels via cAMP-depen-
dent phosphorylation of these channels [26]. Indeed, generation
of cAMP by forskolin or 3-isobutyl-1-methylxanthine increased
[Ca2]1 of the HIT B-cell line [27]. PTH stimulates cyclic AMP
production by pancreatic islets [I], and it is therefore possible
that the hormone mediates at least part of its effect on [Ca2]1 of
islets through its action on adenylate cyclase-cyclic AMP
system. Indeed, our data demonstrate that dibutyryl cAMP
produced a significant rise in [Ca2] of islets, and verapamil, as
in the case of PTH, significantly blocked this effect of cAMP.
These observations are consistent with the notion that the
action of PTH on the L-type calcium channel is mediated, at
least partly, via cAMP.
Certain data indicate that guanosine tnphosphate binding
proteins (G proteins) also modulate the activity of the L-type
voltage dependent calcium channels [28] with [29] or without
[30] the involvement of cAMP, and Gs protein can directly
activate such channels [31]. PTH activates G proteins or
multiple 0 protein-subunits in kidney and bone [32, 33], and it
is reasonable to suggest that PTH may stimulate G proteins of
pancreatic islets as well. Such an action may underlie the effect
of the hormone on the [Ca2], of islets. Certain observations in
our study support this proposition. First, G protein activator
increased [Ca2]1 of islets, and second, both G protein inhibitor
and pertussis toxin which prevents receptor-mediated pro-
cesses that utilizes G proteins, produced marked and significant
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by opening other calcium channels that may not be blocked by
verapamil and/or through mobilization of calcium from intracel-
lular pools. This proposition does not necessarily contradict our
finding that TPA does not stimulate a rise of [Ca2] in the
absence of calcium in the media. Under such circumstances,
the islets may be depleted of calcium and, therefore, mobiliza-
tion of calcium from intracellular pools many be limited.
Indeed, [Ca2]1 of islets incubated in calcium free media is
significantly reduced.
We have shown that PTH stimulates protein kinase C of the
islets of normal rats [2], an effect that would provide another
pathway through which the hormone causes a rise in [Ca2i1 of
the islet. Indeed, staurosporine produced significant inhibition
(57%) of the PTH-induced rise in islets [Ca2]1. Further, the
combination of verapamil and staurosporin produced greater
inhibition of the PTH-induced rise in [Ca2 f]than that produced
by each agent alone.
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Referencesreduction in the PTH-induced rise in [Ca2i of islets. It should
be emphasized that for the G protein activator and inhibitor to
produce their action, they need to penetrate the cells. The
permeability of the islets to these agents was not examined.
However, pertussis toxin enters the cells and its effect is similar
to that of the G protein inhibitor. If these compounds do not
enter the islets, they must therefore exert their effects through
an action on the islets membrane. The nature of such a potential
interaction is not known.
Studies on the effects of activation of protein kinase C on
[Ca2} of rat islets are not available. However, DiVirgilio et al
[34] using Quin 2 did not find a rise in [Ca2] of RINm5F
insulinoma cells after the exposure to TPA, an activator of
protein kinase C. In contrast, Yada, Russo and Sharp [35]
utilizing fura 2 found that TPA causes a rise in [Ca2] of this
cell line and that this effect was blocked by the calcium channel
blockers nitrendipine and verapamil. They concluded that acti-
vation of protein kinase C depolarizes the cell membrane,
induces the opening of the L-type calcium channels and permits
entry of calcium into the cells. Our results to a certain extent
are in agreement with those of Yada et al [35] in that TPA
produced a dose dependent rise in [Ca2 f] This effect was
markedly blocked by staurosporine, an inhibitor of protein
kinase C activity, but only modestly blocked by verapamil.
Thus, it appears that activation of protein kinase C of rat islets
depolarizes their membranes and allow calcium entry into them
leading to a rise in [Ca2]. However, the failure of verapamil in
our study to completely block the effect of TPA as in the studies
of Yada et al [35] may be related to differences between
RINm5F cells and islets of normal rats. Our observation
permits the suggestion that activation of protein kinase C may
increase [Ca2]1 of rat islets through an additional pathway or
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